{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:41:28Z","timestamp":1792788088682,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":91,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Natural Science Foundation of China","award":["82573270"],"award-info":[{"award-number":["82573270"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the National Natural Science Foundation of China","award":["82403091"],"award-info":[{"award-number":["82403091"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3402100"],"award-info":[{"award-number":["2023YFC3402100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the China Postdoctoral Science Foundation","award":["2025M782066"],"award-info":[{"award-number":["2025M782066"]}],"id":[{"id":"https:\/\/ror.org\/0426zh255","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-026-03819-8","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T01:44:38Z","timestamp":1784166278000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A USP15\/KRT17-associated 13-gene prognostic cluster and functional validation in EGFR-mutant lung adenocarcinoma"],"prefix":"10.1186","volume":"27","author":[{"given":"Jiamin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiwei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minzhe","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxiu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaokai","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyun","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaoling","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"issue":"21","key":"3819_CR1","first-page":"1906","volume":"333","author":"SY Kim","year":"2025","unstructured":"Kim SY, Park HS, Chiang AC. Small Cell Lung Cancer: Rev Jama. 2025;333(21):1906\u201317.","journal-title":"Small Cell Lung Cancer: Rev Jama"},{"issue":"6","key":"3819_CR2","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/s43018-025-00996-1","volume":"6","author":"A Thomas","year":"2025","unstructured":"Thomas A, Mohindroo C, Giaccone G. Advancing therapeutics in small-cell lung cancer. Nat Cancer. 2025;6(6):938\u201353.","journal-title":"Nat Cancer"},{"issue":"3","key":"3819_CR3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41571-024-00979-8","volume":"22","author":"Y Wang","year":"2025","unstructured":"Wang Y, et al. Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions. Nat Rev Clin Oncol. 2025;22(3):200\u201314.","journal-title":"Nat Rev Clin Oncol"},{"issue":"10454","key":"3819_CR4","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0140-6736(24)01029-8","volume":"404","author":"ML Meyer","year":"2024","unstructured":"Meyer ML, et al. New promises and challenges in the treatment of advanced non-small-cell lung cancer. Lancet. 2024;404(10454):803\u201322.","journal-title":"Lancet"},{"issue":"2","key":"3819_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41571-024-00971-2","volume":"22","author":"F Zhou","year":"2025","unstructured":"Zhou F, et al. The changing treatment landscape of EGFR-mutant non-small-cell lung cancer. Nat Rev Clin Oncol. 2025;22(2):95\u2013116.","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"3819_CR6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s43018-021-00195-8","volume":"2","author":"A Passaro","year":"2021","unstructured":"Passaro A, et al. Overcoming therapy resistance in EGFR-mutant lung cancer. Nat Cancer. 2021;2(4):377\u201391.","journal-title":"Nat Cancer"},{"issue":"7","key":"3819_CR7","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jtho.2024.03.016","volume":"19","author":"M Borgeaud","year":"2024","unstructured":"Borgeaud M, et al. Unveiling the Landscape of Uncommon EGFR Mutations in NSCLC-A Systematic Review. J Thorac Oncol. 2024;19(7):973\u201383.","journal-title":"J Thorac Oncol"},{"issue":"suppl1","key":"3819_CR8","doi-asserted-by":"publisher","first-page":"i20","DOI":"10.1093\/annonc\/mdx704","volume":"29","author":"J Remon","year":"2018","unstructured":"Remon J, et al. Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patients. Ann Oncol. 2018;29(suppl1):i20\u20137.","journal-title":"Ann Oncol"},{"issue":"suppl1","key":"3819_CR9","doi-asserted-by":"publisher","first-page":"i3","DOI":"10.1093\/annonc\/mdx702","volume":"29","author":"WH Hsu","year":"2018","unstructured":"Hsu WH, et al. Overview of current systemic management of EGFR-mutant NSCLC. Ann Oncol. 2018;29(suppl1):i3\u20139.","journal-title":"Ann Oncol"},{"issue":"7","key":"3819_CR10","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.annonc.2025.03.007","volume":"36","author":"O Mubarak","year":"2025","unstructured":"Mubarak O, Middleton GW. The impact of the immunological context on outcomes of solid cancer patients treated with genotype-matched targeted therapies: a comprehensive review. Ann Oncol. 2025;36(7):737\u201348.","journal-title":"Ann Oncol"},{"issue":"6","key":"3819_CR11","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1038\/s41591-025-03638-2","volume":"31","author":"S Zhao","year":"2025","unstructured":"Zhao S, et al. Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1\/2 and phase 2 trials. Nat Med. 2025;31(6):1976\u201386.","journal-title":"Nat Med"},{"issue":"11","key":"3819_CR12","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1016\/j.cell.2025.03.018","volume":"188","author":"Z Liu","year":"2025","unstructured":"Liu Z, et al. A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer. Cell. 2025;188(11):3081\u2013e309619.","journal-title":"Cell"},{"issue":"2","key":"3819_CR13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jtho.2023.10.001","volume":"19","author":"P Stockhammer","year":"2024","unstructured":"Stockhammer P, et al. Co-Occurring Alterations in Multiple Tumor Suppressor Genes Are Associated With Worse Outcomes in Patients With EGFR-Mutant Lung Cancer. J Thorac Oncol. 2024;19(2):240\u201351.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"3819_CR14","doi-asserted-by":"publisher","first-page":"20952","DOI":"10.1038\/s41598-025-03422-9","volume":"15","author":"J Li","year":"2025","unstructured":"Li J, et al. Osimertinib plus chemotherapy versus osimertinib for patients with advanced NSCLC with concomitant EGFR and TP53 mutations: a prospective cohort study. Sci Rep. 2025;15(1):20952.","journal-title":"Sci Rep"},{"issue":"1","key":"3819_CR15","doi-asserted-by":"publisher","first-page":"5080","DOI":"10.1038\/s41467-024-49492-7","volume":"15","author":"S Liu","year":"2024","unstructured":"Liu S, et al. Alkali cation-induced cathodic corrosion in Cu electrocatalysts. Nat Commun. 2024;15(1):5080.","journal-title":"Nat Commun"},{"issue":"7878","key":"3819_CR16","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41586-021-03898-1","volume":"597","author":"JP Robichaux","year":"2021","unstructured":"Robichaux JP, et al. Structure-based classification predicts drug response in EGFR-mutant NSCLC. Nature. 2021;597(7878):732\u20137.","journal-title":"Nature"},{"issue":"1","key":"3819_CR17","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41746-025-02172-2","volume":"8","author":"Z Gong","year":"2025","unstructured":"Gong Z, et al. Machine learning identifies TIME subtypes linking EGFR mutations and immune states in lung adenocarcinoma. NPJ Digit Med. 2025;8(1):796.","journal-title":"NPJ Digit Med"},{"issue":"6","key":"3819_CR18","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41568-025-00803-0","volume":"25","author":"KL Simpson","year":"2025","unstructured":"Simpson KL, et al. Challenges of small cell lung cancer heterogeneity and phenotypic plasticity. Nat Rev Cancer. 2025;25(6):447\u201362.","journal-title":"Nat Rev Cancer"},{"issue":"7957","key":"3819_CR19","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41586-023-05783-5","volume":"616","author":"AM Frankell","year":"2023","unstructured":"Frankell AM, et al. The evolution of lung cancer and impact of subclonal selection in TRACERx. Nature. 2023;616(7957):525\u201333.","journal-title":"Nature"},{"key":"3819_CR20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3389\/fgene.2019.00493","volume":"10","author":"D Chen","year":"2019","unstructured":"Chen D, et al. Genome-Wide Analysis of Lung Adenocarcinoma Identifies Novel Prognostic Factors and a Prognostic Score. Front Genet. 2019;10:493.","journal-title":"Front Genet"},{"issue":"1","key":"3819_CR21","doi-asserted-by":"publisher","first-page":"5983","DOI":"10.1038\/s41467-022-33365-y","volume":"13","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, et al. The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis. Nat Commun. 2022;13(1):5983.","journal-title":"Nat Commun"},{"issue":"1","key":"3819_CR22","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1038\/s41467-021-22801-0","volume":"12","author":"F Wu","year":"2021","unstructured":"Wu F, et al. Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer. Nat Commun. 2021;12(1):2540.","journal-title":"Nat Commun"},{"issue":"1","key":"3819_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12943-025-02287-w","volume":"24","author":"X Cui","year":"2025","unstructured":"Cui X, et al. Single-cell and spatial transcriptomic analyses revealing tumor microenvironment remodeling after neoadjuvant chemoimmunotherapy in non-small cell lung cancer. Mol Cancer. 2025;24(1):111.","journal-title":"Mol Cancer"},{"key":"3819_CR24","doi-asserted-by":"crossref","unstructured":"Nooreldeen R, Bach H. Current and Future Development in Lung Cancer Diagnosis. Int J Mol Sci. 2021;22(16):8661.","DOI":"10.3390\/ijms22168661"},{"issue":"1","key":"3819_CR25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cell.2023.12.004","volume":"187","author":"Q Liu","year":"2024","unstructured":"Liu Q, et al. Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies. Cell. 2024;187(1):184\u2013e20328.","journal-title":"Cell"},{"issue":"4","key":"3819_CR26","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.molcel.2015.05.004","volume":"58","author":"JA Reuter","year":"2015","unstructured":"Reuter JA, Spacek DV, Snyder MP. High-throughput sequencing technologies. Mol Cell. 2015;58(4):586\u201397.","journal-title":"Mol Cell"},{"key":"3819_CR27","doi-asserted-by":"publisher","first-page":"1770711","DOI":"10.3389\/fimmu.2026.1770711","volume":"17","author":"Y Wang","year":"2026","unstructured":"Wang Y, et al. The value of Protein Phosphatase Methylesterase 1 in diagnosis, prognosis and immunoregulation: from pan-cancer analysis to breast cancer verification. Front Immunol. 2026;17:1770711.","journal-title":"Front Immunol"},{"key":"3819_CR28","first-page":"1439","volume":"17","author":"Y Gou","year":"2025","unstructured":"Gou Y, et al. Integrated Pan-Cancer Profiling and Breast Cancer Validation Identify BEND3 as a Potential Prognostic and Immune Biomarker. Breast Cancer (Dove Med Press). 2025;17:1439\u201361.","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"3819_CR29","doi-asserted-by":"publisher","first-page":"1667589","DOI":"10.3389\/fonc.2025.1667589","volume":"15","author":"J Wang","year":"2025","unstructured":"Wang J, et al. CLIC6\u2019s role in cancer: from broad analysis to breast cancer validation. Front Oncol. 2025;15:1667589.","journal-title":"Front Oncol"},{"key":"3819_CR30","doi-asserted-by":"publisher","first-page":"1670526","DOI":"10.3389\/fonc.2025.1670526","volume":"15","author":"D Elihamu","year":"2025","unstructured":"Elihamu D, et al. CORO1A: a pan-cancer prognosis, diagnostic and immune biomarker based on breast cancer validation. Front Oncol. 2025;15:1670526.","journal-title":"Front Oncol"},{"issue":"1","key":"3819_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41580-021-00407-0","volume":"23","author":"JG Greener","year":"2022","unstructured":"Greener JG, et al. A guide to machine learning for biologists. Nat Rev Mol Cell Biol. 2022;23(1):40\u201355.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"3819_CR32","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1038\/s41598-024-52814-w","volume":"14","author":"T Abd El-Hafeez","year":"2024","unstructured":"Abd El-Hafeez T, et al. Harnessing machine learning to find synergistic combinations for FDA-approved cancer drugs. Sci Rep. 2024;14(1):2428.","journal-title":"Sci Rep"},{"issue":"5","key":"3819_CR33","doi-asserted-by":"publisher","first-page":"e2408750","DOI":"10.1002\/smll.202408750","volume":"21","author":"T Li","year":"2025","unstructured":"Li T, et al. Machine Learning-Engineered Nanozyme System for Synergistic Anti-Tumor Ferroptosis\/Apoptosis Therapy. Small. 2025;21(5):e2408750.","journal-title":"Small"},{"issue":"3","key":"3819_CR34","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/s41591-024-02856-4","volume":"30","author":"MY Lu","year":"2024","unstructured":"Lu MY, et al. A visual-language foundation model for computational pathology. Nat Med. 2024;30(3):863\u201374.","journal-title":"Nat Med"},{"issue":"3","key":"3819_CR35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.tips.2022.12.005","volume":"44","author":"J Kim","year":"2023","unstructured":"Kim J, et al. Computational and artificial intelligence-based methods for antibody development. Trends Pharmacol Sci. 2023;44(3):175\u201389.","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"3819_CR36","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41588-024-02044-7","volume":"57","author":"H Loya","year":"2025","unstructured":"Loya H, et al. A scalable variational inference approach for increased mixed-model association power. Nat Genet. 2025;57(2):461\u20138.","journal-title":"Nat Genet"},{"issue":"1","key":"3819_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12967-022-03369-9","volume":"20","author":"Q Li","year":"2022","unstructured":"Li Q, et al. XGBoost-based and tumor-immune characterized gene signature for the prediction of metastatic status in breast cancer. J Transl Med. 2022;20(1):177.","journal-title":"J Transl Med"},{"issue":"1","key":"3819_CR38","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s12967-023-04205-4","volume":"21","author":"Z Fan","year":"2023","unstructured":"Fan Z, et al. Construction and validation of prognostic models in critically Ill patients with sepsis-associated acute kidney injury: interpretable machine learning approach. J Transl Med. 2023;21(1):406.","journal-title":"J Transl Med"},{"issue":"1","key":"3819_CR39","doi-asserted-by":"publisher","first-page":"5266","DOI":"10.1038\/s41467-024-49450-3","volume":"15","author":"S Martinez","year":"2024","unstructured":"Martinez S, et al. In vivo CRISPR screens reveal SCAF1 and USP15 as drivers of pancreatic cancer. Nat Commun. 2024;15(1):5266.","journal-title":"Nat Commun"},{"issue":"3","key":"3819_CR40","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nm.2619","volume":"18","author":"PJ Eichhorn","year":"2012","unstructured":"Eichhorn PJ, et al. USP15 stabilizes TGF-\u03b2 receptor I and promotes oncogenesis through the activation of TGF-\u03b2 signaling in glioblastoma. Nat Med. 2012;18(3):429\u201335.","journal-title":"Nat Med"},{"issue":"6","key":"3819_CR41","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/ni.2885","volume":"15","author":"Q Zou","year":"2014","unstructured":"Zou Q, et al. USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses. Nat Immunol. 2014;15(6):562\u201370.","journal-title":"Nat Immunol"},{"issue":"1","key":"3819_CR42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12929-022-00824-z","volume":"29","author":"TH Jang","year":"2022","unstructured":"Jang TH, et al. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin\/FAK\/Src\/ERK\/\u03b2-catenin pathway. J Biomed Sci. 2022;29(1):42.","journal-title":"J Biomed Sci"},{"issue":"10","key":"3819_CR43","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s13258-023-01437-y","volume":"45","author":"L Wu","year":"2023","unstructured":"Wu L, et al. Interference KRT17 reverses doxorubicin resistance in triple-negative breast cancer cells by Wnt\/\u03b2-catenin signaling pathway. Genes Genomics. 2023;45(10):1329\u201338.","journal-title":"Genes Genomics"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-026-03819-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03819-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03819-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:02:55Z","timestamp":1792072975000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-026-03819-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3819"],"URL":"https:\/\/doi.org\/10.1186\/s12931-026-03819-8","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"1 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was a secondary analysis conducted using publicly available datasets. Therefore, institutional ethical approval and informed patient consent were not directly required for this specific study. All original data utilized were previously collected by the respective databases in accordance with the ethical standards of the Declaration of Helsinki. Clinical trial number: not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"404"}}